A combined DTaP-IPV vaccine (Tetraxim®/Tetravac®) used as school-entry booster: a review of more than 20 years of clinical and post-marketing experience

C Huoi, J Vargas-Zambrano, D Macina… - Expert Review of …, 2022 - Taylor & Francis
Introduction Routine infant primary series and toddler booster vaccination are associated
with waning of antibody levels over time, which can lead to an increased incidence of …

Review of scientific evidence to support recommendations of the full-dose DTaP-IPV vaccination in pre-school age children in Italy

A Bechini, B Zanella, B Bonito, P Bonanni… - Expert Review of …, 2022 - Taylor & Francis
Introduction Two vaccine formulations are available to prevent diphtheria, tetanus, pertussis,
and poliomyelitis: the pediatric full-dose (DTaP-IPV) and the reduced dose formulation …

[HTML][HTML] A DTAP–IPV//PRP~ T VACCINE: A REVIEW OF 16 YEARS'CLINICAL EXPERIENCE

SA Plotkin, J Liese, SA Madhi, E Ortiz - Current Pediatrics, 2012 - vsp.spr-journal.ru
Owing to their low reactogenicity, confirmed efficacy and availability in combination
vaccines, acellular pertussis (aP)-inactivated poliovirus (IPV) combined vaccines are now …

Booster vaccination: the role of reduced antigen content vaccines as a preschool booster

G Gabutti, C Trucchi, M Conversano… - BioMed Research …, 2014 - Wiley Online Library
The need for boosters for tetanus, diphtheria, pertussis, and polio, starting from preschool
age, is related to the waning immune protection conferred by vaccination, the …

Safety and immunogenicity of DTaP5-IPV compared with DTaP5 plus IPV as the fifth dose in children 4–6 years of age

MJ Smith, E Jordanov, X Sheng… - The Pediatric Infectious …, 2017 - journals.lww.com
Background: Immunogenicity and safety of stand-alone diphtheria, tetanus toxoid, 5-
component acellular pertussis vaccine adsorbed, inactivated poliovirus (IPV) combination …

Immunogenicity and safety of a DTaP-IPV//PRP∼ T vaccine (Pentaxim) booster dose during the second year of life in Indian children primed with the same vaccine

AK Dutta, VP Verghese, H Pemde, LG Mathew, E Ortiz - Indian pediatrics, 2012 - Springer
Objective To evaluate the immunogenicity and safety of a pentavalent (diphtheria, tetanus,
acellular pertussis, inactivated poliovirus, Hib polysaccharide-conjugate) combination …

Kinrix™: a new combination DTaP–IPV vaccine for children aged 4–6 years

WM Weston, NP Klein - Expert Review of Vaccines, 2008 - Taylor & Francis
Combination vaccines allow the administration of multiple vaccine antigens without the need
for multiple injections. Recently, a combined diphtheria toxoid, tetanus toxoid, acellular …

Repeated administration of a reduced-antigen-content diphtheria-tetanus-acellular pertussis and poliomyelitis vaccine (dTpa-IPV; Boostrix™ IPV)

M Knuf, V Vetter, F Celzo, G Ramakrishnan… - Human …, 2010 - Taylor & Francis
Background: The rising incidence of pertussis amongst adults and adolescents in
industrialised countries could be reduced by replacing tetanus and diphtheria (Td) boosters …

Diphtheria, tetanus and poliovirus antibody persistence 5 years after vaccination of pre-schoolers with two different diphtheria, tetanus and inactivated poliomyelitis …

V Gajdos, E Vidor, P Richard, C Tran, C Sadorge - Vaccine, 2015 - Elsevier
Introduction This follow-up study assessed the 5-year persistence of vaccine-induced
antibodies (Td-IPV or DT-IPV) and the immune response to a booster dose of DTaP-IPV …

[PDF][PDF] Clinical evaluation of a DTaP-HepB-IPV combined vaccine

BSN Susan Partridge, SH Yeh - The American journal of …, 2003 - ajmc.s3.amazonaws.com
Objective: To provide an overview of prelicensure clinical data for a new pediatric vaccine
that combines diphtheria, tetanus, acellular pertussis, hepatitis B, and inactivated poliovirus …